Xiao M - Search Results

1

STRN3-NTRK1: A Novel NTRK1 Oncogenic Fusion in a Patient with Lung Adenocarcinoma.

Lu R, Qi C, Xiao M, Cai S, Zheng M. Lu R, et al. Among authors: xiao m. J Thorac Oncol. 2020 Feb;15(2):e23-e24. doi: 10.1016/j.jtho.2019.08.2508. J Thorac Oncol. 2020. PMID: 32127185 Free article. No abstract available.

2

Identification of a Novel Osimertinib-Sensitive Mutation, EGFR H773L, in a Chinese Patient With NSCLC.

Zhang Q, Jiang T, Xiao M, Zhang J, Ying X. Zhang Q, et al. Among authors: xiao m. J Thorac Oncol. 2020 Mar;15(3):e46-e48. doi: 10.1016/j.jtho.2019.11.018. J Thorac Oncol. 2020. PMID: 32093862 Free article. No abstract available.

3

A Novel Oncogenic RET Fusion Variant in Non-Small Cell Lung Cancer: RELCH-RET.

Jiang H, Xiao M, Qi C, Cai S, Liu F. Jiang H, et al. Among authors: xiao m. J Thorac Oncol. 2020 Feb;15(2):e27-e28. doi: 10.1016/j.jtho.2019.08.2510. J Thorac Oncol. 2020. PMID: 32127187 Free article. No abstract available.

4

A Novel Intergenic LSM14A-RET Fusion Variant in a Patient With Lung Adenocarcinoma.

Lv Y, Ling F, Zhang J, Xiao M, Mao W. Lv Y, et al. Among authors: xiao m. J Thorac Oncol. 2020 Apr;15(4):e52-e53. doi: 10.1016/j.jtho.2019.11.025. J Thorac Oncol. 2020. PMID: 32216946 Free article. No abstract available.

5

EPS15-NTRK1: a novel NTRK1 oncogenic fusion in patient with lung adenocarcinoma.

Yang S, Li L, Chen D, Xiao M, Xian L. Yang S, et al. Among authors: xiao m. J Cancer Res Clin Oncol. 2020 Dec;146(12):3389-3392. doi: 10.1007/s00432-020-03416-2. Epub 2020 Oct 9. J Cancer Res Clin Oncol. 2020. PMID: 33037466 No abstract available.

6

The value and inadequacy of tumor mutation burden on efficacy of immune checkpoint inhibitors in head and neck cancers.

Ma HH, Chen DS, Li S, Xiao MZ, Qi C. Ma HH, et al. Oral Oncol. 2021 Jun;117:105179. doi: 10.1016/j.oraloncology.2021.105179. Epub 2021 Jan 26. Oral Oncol. 2021. PMID: 33514453 No abstract available.

7

PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non-small cell lung cancer.

Dong Y, Zhao L, Duan J, Bai H, Chen D, Li S, Yu Y, Xiao M, Zhang Q, Duan Q, Sun T, Qi C, Wang J, Wang Z. Dong Y, et al. Among authors: xiao m. Cell Prolif. 2022 Sep;55(9):e13283. doi: 10.1111/cpr.13283. Epub 2022 Jul 10. Cell Prolif. 2022. PMID: 35811392 Free PMC article.

8

NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.

Gong XY, Chen HB, Zhang LQ, Chen DS, Li W, Chen DH, Xu J, Zhou H, Zhao LL, Song YJ, Xiao MZ, Deng WL, Qi C, Wang XR, Chen X. Gong XY, et al. Front Immunol. 2022 Jul 15;13:920253. doi: 10.3389/fimmu.2022.920253. eCollection 2022. Front Immunol. 2022. PMID: 35911687 Free PMC article.

9

SLIT mutations as potential predictive biomarkers for immunotherapy in NSCLC.

Zhou T, Yi H, Zhu C, Yu Y, He Q, Xiao M, Qi C, Lu T. Zhou T, et al. Among authors: xiao m. Invest New Drugs. 2023 Apr;41(2):251-253. doi: 10.1007/s10637-023-01355-6. Epub 2023 Apr 10. Invest New Drugs. 2023. PMID: 37036581 No abstract available.

10

Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.

Hu S, Liu Y, Yang Q, Chen L, Chai H, Xiao M, Qi C, Qiu W. Hu S, et al. Among authors: xiao m. Invest New Drugs. 2023 Jun;41(3):532-538. doi: 10.1007/s10637-023-01363-6. Epub 2023 Apr 26. Invest New Drugs. 2023. PMID: 37099161 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,279 results

Search Page

Filters